By jurisdiction

Canada (Health Canada)

Every compound we track that has a recorded status under Canada (Health Canada). Tap a name for the full picture, including the U.S. status and primary sources.

Canada (Health Canada): status by compound
CompoundStatus hereNote
CagrilintideUnder reviewCagrilintide/semaglutide new drug submission (Novo Nordisk) accepted into Health Canada review in March 2026; no cagrilintide product yet authorized in the Drug Product Database.
BPC-157RestrictedNot an authorized drug; Health Canada's April 2026 advisory names BPC-157 among unauthorized injectable peptides and states such products are illegal to sell in Canada.
CJC-1295RestrictedNot authorized by Health Canada; named in an April 2026 public advisory on unauthorized injectable peptides, which states such products are illegal to sell and reports seizures.
Emideltide (DSIP)RestrictedNot authorized in Canada; Health Canada's April 2026 advisory names DSIP among unauthorized injectable peptide drugs that are illegal to sell.
EpitalonRestrictedNamed in Health Canada's April 2026 advisory on unauthorized injectable peptides; absent from the Drug Product Database, so sale for human use is illegal under the Food and Drugs Act.
GHK-CuRestrictedNot in the Drug Product Database; Health Canada recalled GHK-Cu powder as an unauthorized active pharmaceutical ingredient in May 2026.
IpamorelinRestrictedNot authorized for sale; Health Canada's April 2026 advisory names ipamorelin as an unauthorized injectable peptide drug that is illegal to sell in Canada.
KPVRestrictedNot authorized for sale; listed in an April 2026 Health Canada advisory among unauthorized injectable peptide drugs it has seized, with peptides generally regulated as prescription drugs in Canada.
Melanotan IIRestrictedNot authorized for sale; Health Canada names Melanotan I and II among unauthorized injectable peptide drugs it has seized, warning that unauthorized drug products are illegal in Canada.
MOTS-cRestrictedNamed in Health Canada's April 2026 advisory on unauthorized injectable peptides; unauthorized drug products are illegal to sell in Canada.
NAD+RestrictedNo approved injectable NAD+ in the Drug Product Database; an April 2026 Health Canada advisory lists NAD+ among unauthorized injectable drugs illegal to sell; oral NAD+ is regulated as a natural health product.
RetatrutideRestrictedNot authorized by Health Canada; named in an April 2026 advisory on unauthorized injectable peptide drugs - unauthorized drug products are illegal to sell in Canada.
SelankRestrictedNot authorized by Health Canada; a 2025 public advisory named Selank among seized unauthorized injectable peptide drugs, stating that selling unauthorized drugs is illegal in Canada.
Semaglutide (compounded)RestrictedAuthorized prescription-only medicine (Ozempic, Wegovy); compounded copies of marketed drugs are not permitted outside a shortage, and Health Canada has recalled compounded semaglutide made with an unauthorized API.
SemaxRestrictedNo Health Canada authorization; named in an August 2025 Health Canada seizure advisory on unauthorized injectable peptides, which cannot legally be sold in Canada.
SermorelinRestrictedNamed on the Prescription Drug List ('Sermorelin or its salts', effective 2013-12-19); no product currently authorized in the Drug Product Database.
TB-500 (Thymosin Beta-4)RestrictedNot authorized for sale; Health Canada has seized TB-500 among unauthorized injectable peptides and states selling unauthorized drugs is illegal in Canada.
Thymosin Alpha-1RestrictedNot authorized for sale; no Drug Product Database listing, and Health Canada named thymosin alpha-1 among unauthorized injectable peptides seized in April 2025.
Tirzepatide (compounded)RestrictedAuthorized prescription-only medicine (Mounjaro); compounded copies of marketed drugs are not permitted outside a shortage, and Health Canada warns selling unauthorized versions is illegal in Canada.